Muneer A. Satter, Director, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), bought 60,000 shares at $1.94 ($108K) on 2019-01-02, disclosed to the SEC on 2019-01-02.
Open-market purchase of $108k ARPO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.72 | 20,000 | $34K | 31.8% |
| 2 | $1.75 | 20,000 | $35K | 32.3% |
| 3 | $1.94 | 20,000 | $39K | 35.9% |
| Total | $1.80 avg | 60,000 | $108K | 100% |
| Filing → |
| ANNX | BUY | 2025-11-19 | $5.1M | — | Filing → |
| ANNX | BUY | 2023-12-28 | $1.0M | — | Filing → |
| ANNX | BUY | 2023-02-14 | $36.0M | — | Filing → |